other material
confidence high
sentiment neutral
materiality 0.60
Alaunos shareholders approve 10x increase in authorized common shares, reverse split authorization
Alaunos Therapeutics, Inc.
- Stockholders approved increasing authorized common shares from 5M to 50M; amendment effective July 10, 2025.
- Authorized reverse stock split at ratio between 1:5 and 1:20, at Board's discretion.
- Stockholders approved raising shares available under 2020 Equity Incentive Plan from 130,745 to 1,130,745.
- Elected directors: Robert W. Postma, Jaime Vieser, Holger Weis; Dale Hogue resigned before meeting and was not reelected.